Programme

Official symposium time zone Central European Summer Time, CEST

9.00-9.15 CEST	Opening
9.15-10.30 CEST	Neuropathology. ApoE and microglia.
	9.15 CEST	Raj Kalaria, Newcastle, UK Update on the pathophysiology of sporadic and familial cerebral small vessel diseases with implications for Alzheimer’s disease
	9.45 CEST	Tarja Malm, Kuopio, Finland
	10.15 CEST	15 min discussion
10.30-11.45 CEST	Neuroinflammation. Glymphatic system.
	10.30 CEST	Pentti Tienari, Helsinki, Finland MHC and neuroinflammation
	11.00 CEST	Tuomas Lilius, Helsinki, Finland Pharmacology of the glymphatic system - implications for neurodegenerative diseases
	11.30 CEST	15 min discussion
11.45-12.30 CEST	BREAK
12.30-13.45 CEST	From clinics to research and back.
	12.30 CEST	Leonardo Pantoni, Milano, Italy How can we detect SVD and degenerative components in our clinical practice and in research?
	13.00 CEST	Miia Kivipelto, Stockholm, Sweden
	13.30 CEST	15 min discussion
13.45-15.25 CEST	From imaging to cognitive and functional status.
	13.45 CEST	Mark Bondi, San Diego, US Associations of MRI locus coeruleus contrast ratio and white matter lesion pathology in nondemented older adults
	14.15 CEST	5 min discussion
	14.20 CEST	Hanna Jokinen-Salmela, Helsinki, Finland Global burden of SVD brain changes
	14.50 CEST	Adam Brickman, New York, US
	15.20 CEST	15 min discussion
15.35-15.45 CEST	Closing of the day

9.15 -10.00 CEST	Short communications/oral presentations
10.00-11.15 CEST	Biomarkers, early diagnostics.
	10.00 CEST	Henrik Zetterberg, Gothenburg, Sweden Development of blood biomarkers for neurodegenerative dementias - goodbye lumbar puncture?
	10.30 CEST	Sanna-Kaisa Herukka, Kuopio, Finland
	11.00 CEST	15 min discussion
11.15-12.30 CEST	Cognition, neuropsychiatry.
	11.15 CEST	Anders Wallin, Gothenburg, Sweden What does investigation of patients seeking help at a memory clinic tell us about the neurovascular unit?
	11.45 CEST	Olivier Godefroy, Amiens, France Poststroke cognitive disorders and their imaging determinants
	12.15 CEST	15 min discussion
12.30-13.15 CEST	BREAK
13.15-14.30 CEST	Treatment perspectives.
	13.15 CEST	Vincent Mok, Hong Kong, China Preventive Treatments of Sporadic Cerebral Small Vessel Disease
	13.45 CEST	Satu Palva, Helsinki, Finland Computational model to stimulate brain function for the diagnosis and individualized treatment of degenerative brain diseases (VirtualBrainCloud).
	14.15 CEST	15 min discussion
14.30-15.45 CEST	Future trials, interaction.
	14.30 CEST	Terry Quinn, Glasgow, UK What would a cSVD/AD trial look like?
	15.00 CEST	TBA
	15.30 CEST	15 min discussion
15.45-16.00 CEST	Closing

The program may be subject to change.